Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|September 20, 1995
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cellsG K Schwartz, A Haimovitz-Friedman, S K Dhupar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acidA D Hoffman, D Engelstein, T Bogenrieder, et al.
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Risk factors for HIV-2 infection in Guinea-BissauL H Harrison, A P da Silva, H D Gayle, et al.
Urologic Oncology|January 14, 2011
Reversal of the low-affinity neurotrophin receptor stromal-epithelial expression pattern between benign and malignant human prostateC N Papandreou, T Bogenrieder, C L Finstad, et al.
The American Journal of Otology|March 1, 1997
DNA analysis of human cholesteatomasR B Desloge, J F Carew, C L Finstad, et al.
International Journal of Cancer|February 20, 1995
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agentsY Nabeya, F Loganzo, P Maslak, et al.
The Journal of Craniofacial Surgery|February 19, 2016
Craniosynostosis Following Fetal Methotrexate ExposureChristopher S Zarella, Frank P Albino, Albert K Oh, et al.
International Journal of Oncology|July 17, 1998
Aminopeptidase A expression and enzymatic activity in primary human renal cancersD M Nanus, T Bogenrieder, C N Papandreou, et al.
Molecular Carcinogenesis|November 4, 2005
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1Anthony P Gulati, Yang-Ming Yang, David Harter, et al.
Pageof 15